Trial Profile
Pivotal phase III trial of intranasal doxepin in patients with chronic migraine
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 29 Nov 2010
Price :
$35
*
At a glance
- Drugs Doxepin (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Winston Pharmaceuticals
- 29 Nov 2010 New trial record